These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 38004502)

  • 61. A study of genetic leukodystrophies in Chinese children.
    Wang PJ; Wang TZ; Shen YZ
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1992; 33(1):44-58. PubMed ID: 1626451
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Ocular gene therapy: an evaluation of recombinant adeno-associated virus-mediated gene therapy interventions for the treatment of ocular disease.
    Roy K; Stein L; Kaushal S
    Hum Gene Ther; 2010 Aug; 21(8):915-27. PubMed ID: 20384478
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Leukodystrophies.
    Perlman SJ; Mar S
    Adv Exp Med Biol; 2012; 724():154-71. PubMed ID: 22411242
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Structural manifestations of leukodystrophies.
    Seitelberger F
    Neuropediatrics; 1984 Sep; 15 Suppl():53-61. PubMed ID: 6152813
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Metachromatic leukodystrophy: genetics, pathogenesis and therapeutic options.
    Gieselmann V
    Acta Paediatr; 2008 Apr; 97(457):15-21. PubMed ID: 18339182
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Leukodystrophies: pathogenesis, diagnosis, strategies, therapies, and future research directions.
    Maria BL; Deidrick KM; Moser H; Naidu S
    J Child Neurol; 2003 Sep; 18(9):578-90. PubMed ID: 14572135
    [No Abstract]   [Full Text] [Related]  

  • 67. Gene Therapy with Hematopoietic Stem Cells: The Diseased Bone Marrow's Point of View.
    Cavazzana M; Ribeil JA; Lagresle-Peyrou C; André-Schmutz I
    Stem Cells Dev; 2017 Jan; 26(2):71-76. PubMed ID: 27750026
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gene therapy of metachromatic leukodystrophy.
    Matzner U; Gieselmann V
    Expert Opin Biol Ther; 2005 Jan; 5(1):55-65. PubMed ID: 15709909
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Atidarsagene autotemcel for metachromatic leukodystrophy.
    Messina M; Gissen P
    Drugs Today (Barc); 2023 Feb; 59(2):63-70. PubMed ID: 36811406
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.
    Sessa M; Lorioli L; Fumagalli F; Acquati S; Redaelli D; Baldoli C; Canale S; Lopez ID; Morena F; Calabria A; Fiori R; Silvani P; Rancoita PM; Gabaldo M; Benedicenti F; Antonioli G; Assanelli A; Cicalese MP; Del Carro U; Sora MG; Martino S; Quattrini A; Montini E; Di Serio C; Ciceri F; Roncarolo MG; Aiuti A; Naldini L; Biffi A
    Lancet; 2016 Jul; 388(10043):476-87. PubMed ID: 27289174
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord.
    Jensen TL; Gøtzsche CR; Woldbye DPD
    Front Mol Neurosci; 2021; 14():695937. PubMed ID: 34690692
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Brain cell type-specific endocytosis of arylsulfatase A identifies limitations of enzyme-based therapies for metachromatic leukodystrophy.
    Kaminski D; Yaghootfam C; Matthes F; Reßing A; Gieselmann V; Matzner U
    Hum Mol Genet; 2021 Feb; 29(23):3807-3817. PubMed ID: 33367737
    [TBL] [Abstract][Full Text] [Related]  

  • 73. New Indications for Hematopoietic Stem Cell Gene Therapy in Lysosomal Storage Disorders.
    Rossini L; Durante C; Marzollo A; Biffi A
    Front Oncol; 2022; 12():885639. PubMed ID: 35646708
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Gene therapy for lysosomal storage disorders: recent advances for metachromatic leukodystrophy and mucopolysaccaridosis I.
    Penati R; Fumagalli F; Calbi V; Bernardo ME; Aiuti A
    J Inherit Metab Dis; 2017 Jul; 40(4):543-554. PubMed ID: 28560469
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Leukodystrophy and bone marrow transplantation: role of mixed hematopoietic chimerism.
    Kaufman CL; Ildstad ST
    Neurochem Res; 1999 Apr; 24(4):537-49. PubMed ID: 10227686
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinical Trials for Gene Therapy in Lysosomal Diseases With CNS Involvement.
    Sevin C; Deiva K
    Front Mol Biosci; 2021; 8():624988. PubMed ID: 34604300
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Gene therapy for PIDs: progress, pitfalls and prospects.
    Mukherjee S; Thrasher AJ
    Gene; 2013 Aug; 525(2):174-81. PubMed ID: 23566838
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
    Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
    Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gene replacement therapies for duchenne muscular dystrophy using adeno-associated viral vectors.
    Seto JT; Ramos JN; Muir L; Chamberlain JS; Odom GL
    Curr Gene Ther; 2012 Jun; 12(3):139-51. PubMed ID: 22533379
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.